FDA InspectionBaxter Pharmaceutical Solutions, LLC
Baxter Pharmaceutical Solutions, LLC – FDA Inspection, May 23, 2018
Record Details
This FDA Inspection record concerns Baxter Pharmaceutical Solutions, LLC, with an inspection on May 23, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
ID · a8a9268a-9813-4e4f-b671-eae53fa1f68d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1060004
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Baxter Pharmaceutical Solutions, LLC
19| Date | Classification | Office | Project area |
|---|---|---|---|
| December 11, 2025 | Not classified | Detroit District Office | Blood and Blood Products |
| September 24, 2024 | Not classified | Detroit District Office | |
| July 26, 2024 | Not classified | Detroit District Office | |
| February 20, 2024 | Not classified | Detroit District Office | |
| February 17, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Or discuss it with
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Baxter Pharmaceutical Solutions, LLC document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA